Table of Contents
Johann Rupert draws no salary from Remgro. He is collecting about $32.8 million from it this year.
All of it comes from dividends. Remgro declared an ordinary dividend of 595 cents a share alongside its results on Friday, Sept. 18, plus a special dividend of 550 cents, making 1,145 cents in total. Every share in the company receives it.
Most of Rupert's money arrives through shares nobody else can buy.
A private company called Rupert Beleggings holds all 39,056,987 of Remgro's unlisted B ordinary shares, and Johann Rupert sits on its board. Those shares are not traded on any exchange, and they carry 43% of the votes at Remgro.
That is how the family controls the group. Remgro holds stakes in the hospital operator Mediclinic, the insurer OUTsurance, Heineken Beverages, TotalEnergies South Africa, the food producer RCL Foods and the fibre network CIVH, and the B shares decide who runs it.
They pay the same dividend as ordinary shares. The 39 million B shares produce $27.5 million of Rupert's total, or 84% of it.
The remainder comes from an associate interest in 7,553,865 ordinary shares, worth $5.3 million to him. He owns no ordinary shares personally.
South Africa taxes dividends at 20%, taking $6.6 million and leaving him about $26.3 million, though exemptions and double-taxation treaties can change that.
Everyone else on the Remgro board received $2.8 million between them.
What paid for it was an exceptional year.
Headline earnings rose 42.3% to $685 million from $481 million. Headline earnings per share rose 42.2% to 20.03 rand from 14.09.
A large part of that will not happen again. Remgro identified $62.9 million of one-off items, made up of a Swiss tax benefit at Mediclinic worth $31.4 million, a tariff provision release of $18.1 million, and Remgro's $13.4 million share of a refund on Transnet pipeline costs at TotalEnergies. Removing those leaves growth of 29.3%.
The group said the quality of its earnings remains sound because the growth came mainly from stronger operational performances at the companies it owns.
Mediclinic contributed an extra $84.1 million, the biggest single improvement. Rainbow added $37.5 million, CIVH $25.3 million, OUTsurance $20.4 million and Heineken Beverages $9.9 million. Selling its FirstRand stake produced $14.1 million in financial income from the proceeds.
Two holdings pulled the other way. RCL Foods contributed $22.6 million less than the year before, and the FirstRand sale cost Remgro $6.8 million in dividends it no longer receives.
The special dividend is the part that stands out. At 550 cents it is almost half the total declared, and it accounts for $15.8 million of what Rupert receives. Companies pay special dividends when they hold cash they do not intend to spend, and they carry no promise of repetition.
Remgro's board said it remains solvent and liquid with sufficient capital and reserves after both payments.
The intelligence satisfies curiosity. The paid briefings satisfy strategy.
Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week's most consequential African wealth story - the kind of analysis that doesn't appear anywhere else.
Twice a month, a Wealth Intelligence brief profiles a single billionaire's holdings, cash flows and expansion pipeline in detail no public source matches.
→ Executive ($25/mo): Daily newsletter + Deep-Dive Reports
→ Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings
Subscribe now
